“Selective Cell Cycle Arrest in Glioblastoma Cell Lines by Quantum Molecular Resonance Alone or in Combination with Temozolomid,” British Journal of Cancer, June 17, 2022.
A new “innovative option” to treat all-too-lethal glioblastoma with 4-64 MHz nanosecond pulses. “Quantum molecular resonance” therapy reduces cell proliferation in malignant cell lines with little effect on healthy cells.
From Italy. Open Access.
